Synchrony's Health & Wellness Bet: A Long-Term Growth Catalyst?

Core Insights - Synchrony Financial is enhancing its presence in the Health & Wellness sector through its CareCredit brand, which is expected to drive long-term growth due to increasing demand for health-related financing in an aging U.S. population [1][4] Health & Wellness Sector - Health spending is projected to reach $5.6 trillion in 2023 and increase to $8.6 trillion by 2033, presenting a significant opportunity for Synchrony [2] - Active accounts in Health & Wellness grew by 13.3% in 2023, 8% in 2024, and 0.7% in the first half of 2025, while interest and fees on loans increased by 13.6% last year and 3.2% in the first half of 2025, indicating strong momentum [2] - By the end of Q2 2025, 15% of Synchrony's loan receivables were associated with Health & Wellness, with a provider network exceeding 285,000 locations [3][8] - The CareCredit network benefits from repeat customers, which enhances purchase volume and reduces reliance on any single partner [3][8] Competitive Landscape - Peers such as American Express and Ally Financial are also experiencing growth in receivables and interest income, with American Express reporting a 6% year-over-year increase in total loans and card member receivables in Q2 2025 [5][6] Financial Performance and Valuation - Synchrony shares have increased by 17.8% year-to-date, outperforming the industry average of 5% [7] - The company trades at a forward price-to-earnings ratio of 8.70, significantly lower than the industry average of 24.77, and holds a Value Score of A [9] - The Zacks Consensus Estimate for Synchrony's 2025 earnings is $8.39 per share, reflecting a 27.3% increase from the previous year [10]